# ABVX: ABIVAX Société Anonyme

- Industry: Biotechnology
- Current price: $114.77
- Price updated: Aug 28, 2026
- Total congressional trades: 1
- Politicians trading: 1
- Last traded: Jul 10, 2026
- Source: https://tryglasshouse.ai/companies/ABVX.md

ABIVAX Société Anonyme, a clinical-stage biotechnology company, develops therapeutics that harness the body's natural regulatory mechanisms to stabilize the immune response in patients with chronic inflammatory diseases. Its lead drug candidate includes obefazimod, which is in Phase 3 clinical development for the treatment of moderately to severely active UC, as well as Phase 2b clinical trials for Crohn's disease. The company was incorporated in 2013 and is headquartered in Paris, France.

# Congressional trading history

- Page: 1 of 1
- Results: 1 of 1
- Pagination query parameter: `page`

## 1. Ro Khanna

- Member: Democrat, House
- Transaction: Buy, $15,001 - $50,000
- Dates: traded Jul 10, 2026, disclosed Aug 7, 2026
- Market context: $139.9 at trade, $114.77 current (-17.96%)
- Politician: https://tryglasshouse.ai/politicians/K000389.md
- Record: https://tryglasshouse.ai/trades/7157ea54-ab12-4b18-acd1-b3ed94bfc0e2.md



Prices and percentage changes are market context, not portfolio returns. This information is not financial advice.